Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Or

(904) 244-0411 MyUFHealth Education Research Community

Treats Adults

James D Cury, MD

Pulmonologist, Critical Care Medicine Physician

4.9 /5 181 ratings

Request appointment online

Established patients New patients

Provider profile Menu

Provider profile Menu

Research at a glance

Top areas of exploration

Lung Neoplasms , 5 publications
Carcinoma, Non-Small-Cell Lung , 4 publications
Proton Therapy , 4 publications
Pulmonary Disease, Chronic Obstructive , 4 publications

Research activity

50 publications

765 citations

Why is this important?

Active clinical trials

A 52-week study assessing exacerbation rate, asthma control and safety in adult severe eosinophilic asthmatics treated with depemokimab compared with mepolizumab or benralizumab

Investigator: James D Cury
Status: Accepting Candidates
Ages: N/A
Sexes: All

Study of Benralizumab in Patients with Chronic Obstructive Pulmonary Disease with a History of Frequent COPD Exacerbations and Elevated Peripheral Blood Eosinophils

Investigator: James D Cury
Status: Accepting Candidates
Ages: 40 Years - 85 Years
Sexes: All

My publications

50 publications

2012

Pulmonary Hypertension Secondary to COPD.

Pulmonary medicine

PubMed • Publisher's site

2012

Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison.

Thoracic cancer

PubMed • Publisher's site

2011

First case of Legionella pneumophila native valve endocarditis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

PubMed • Publisher's site

2011

Poorly treated or unrecognized GERD reduces quality of life in patients with COPD.

Digestive diseases and sciences

PubMed • Publisher's site

2011

Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.

Clinical lung cancer

PubMed • Publisher's site